UROGEN PHARMA LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.08 USD | -0.34% |
|
-3.86% | -12.77% |
| Jun. 03 | UroGen Pharma Appoints David Lin as New Chief Commercial Officer | CI |
| May. 14 | Oppenheimer Lowers UroGen Pharma Price Target to $32 From $34, Maintains Outperform Rating | MT |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-05-30 | 2024-05-31 | 2024-06-03 | 2024-06-04 | |
|---|---|---|---|---|
| Last | 13.55 $ | 13.3 $ | 13.13 $ | 13.08 $ |
| Volume | 332 164 | 112 219 | 206 674 | 315 457 |
| Change | +2.19% | -1.85% | -1.28% | -0.38% |
| Opening | 13.40 | 13.61 | 13.50 | 13.16 |
| High | 13.83 | 13.84 | 13.76 | 13.24 |
| Low | 13.21 | 13.24 | 13.09 | 12.87 |
Performance
| 1 day | -0.34% | ||
| 1 week | -3.86% | ||
| Current month | -1.62% | ||
| 1 month | -8.50% | ||
| 3 months | -28.96% | ||
| 6 months | -1.84% | ||
| Current year | -12.77% | ||
| 1 year | +34.34% | ||
| 3 years | -27.22% | ||
| 5 years | -63.05% |
Volumes
marketsDaily volume
315 457
Estimated daily volume
315 457
Avg. Volume 20 sessions
290 209
Daily volume ratio
1.09
Avg. Volume 20 sessions USD
3 797 384.77
Record volume 1
9 466 033
Record volume 2
7 930 960
Record volume 3
3 245 234
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (USD)
472 581 982
Net sales (USD)
82 713 000
Number of employees
204
Sales / Employee (USD)
405 456
Free-Float
89.16 %
Free-Float capitalization (USD)
421 348 603
Average Daily Capital Traded
0.8%
Highs and lows
1 week
12.87
13.84
1 month
10.6014.89
Current year
10.6019.87
1 year
8.6924.13
3 years
4.8524.13
5 years
4.8538.03
10 years
4.8569.57
Indicators
Moving average 5 days
13.26
Moving average 20 days
13.25
Moving average 50 days
13.87
Moving average 100 days
15.25
Price spread / (MMA5)
+1.37%
Price spread / (MMA20)
+1.24%
Price spread / (MMA50)
+5.97%
Price spread / (MMA100)
+16.58%
STIM
RSI 9 days
45.34
RSI 14 days
45.21
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -0.34% | -3.86% | -12.77% | +34.34% | 473M | ||
| +1.02% | +6.29% | +16.73% | +42.30% | 123B | ||
| +0.34% | +2.02% | +13.04% | +34.18% | 107B | ||
| -3.35% | +5.65% | -5.80% | -8.06% | 24.01B | ||
| +0.55% | +3.44% | +1.69% | -5.36% | 22.59B | ||
| -0.82% | +0.16% | -10.09% | -28.82% | 18.16B | ||
| +3.05% | +2.41% | -40.52% | -36.20% | 16.84B | ||
| +6.07% | +1.31% | -14.00% | -31.78% | 16.23B | ||
| -4.72% | -5.10% | +1.18% | +44.41% | 13.43B | ||
| -3.61% | +5.66% | +24.18% | -4.32% | 11.32B | ||
| +1.75% | +18.44% | +83.67% | +191.30% | 9.19B | ||
| -1.84% | +3.22% | +12.91% | +39.78% | 7.72B | ||
| -0.69% | +5.53% | +6.69% | +47.17% | 7.71B | ||
| 0.00% | -0.90% | -4.17% | +21.72% | 7.41B | ||
| +3.20% | -0.89% | -31.34% | -34.82% | 7.54B | ||
| -9.70% | -13.97% | +202.15% | +152.38% | 6.2B | ||
| Average | +0.14% | +1.83% | +15.22% | +28.64% | ||
| Weighted average by Cap. | +0.39% | +3.50% | +11.15% | +26.90% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
5.gDewUMIPXMMfkVQat84Ru-GDSao23meZfdVuq96RDIk.7Vn-MYVnA7lnoxsqgad-6IbhBuZzjC_NGuUq2KzYR8ThUYY9q1U5kVq8YA
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 03:59:47 pm | 13.08 | 100 | 169,913 |
| 03:59:41 pm | 13.08 | 215 | 169,813 |
| 03:59:41 pm | 13.08 | 300 | 169,598 |
| 03:59:41 pm | 13.08 | 100 | 169,298 |
| 03:59:39 pm | 13.1 | 100 | 169,198 |
| 03:59:39 pm | 13.1 | 100 | 169,098 |
| 03:59:39 pm | 13.1 | 100 | 168,998 |
| 03:59:33 pm | 13.1 | 100 | 168,898 |
| 03:59:31 pm | 13.1 | 157 | 168,798 |
| 03:59:24 pm | 13.09 | 100 | 168,641 |
Monthly variations
Annual change
| 2024 | -12.80% | ||
| 2023 | +69.11% | ||
| 2022 | -6.73% | ||
| 2021 | -47.23% | ||
| 2020 | -46.00% | ||
| 2019 | -22.50% | ||
| 2018 | +15.72% | ||
| 2017 | +166.17% |
- Stock Market
- Equities
- URGN Stock
- Quotes UroGen Pharma Ltd.
